Project Grant R43AI177129
Award Date 8/1/23
Completion Date 7/31/24
Dollars Obligated $300K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,000,000 Project Grant to Partillion Bioscience Corp, a biotechnology company based in Los Angeles, California. The grant, funded under NIAID's Allergy and Infectious Diseases Research program (CFDA 93.855), supports the development of advanced workflows utilizing Partillion's specialized hydrogel microparticle technology called "nanovials". The goal is to enable ultra high-throughput screening and functional...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Scripps Research Institute a Project Grant of $910,905 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 1, 2025 through June 30, 2026. Under this award, Scripps Research Institute will advance HIV vaccine development by incorporating engineered transmembrane envelope (ENV) glycoprotein vaccine candidates into stable lipid nanodiscs using membrane scaffold...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $506,000 to the Scripps Research Institute under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 9, 2025, for a project titled "Development of siRNA-Peptide Libraries for Delivery Screening." The project, which extends through June 30, 2027, addresses a critical gap in the clinical translation of small interfering RNA (siRNA) therapeutics by developing...
- Federal Grant Award Summary Award Details: The National Institute of Allergy and Infectious Diseases (NIAID) awarded $304,602 to Protabit, LLC on August 7, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The project period extends through July 31, 2026. Deliverables and Services: Protabit will develop a high-throughput protein engineering platform for the design and optimization of bispecific IgG antibodies, which are therapeutic biologic molecules with...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $299,995 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Xiretsa Inc., a minority-owned small business located in Santa Barbara, CA. The grant will fund the development of a novel class of antimicrobial compounds called Anti-Infective Conjugated Electrolytes (ACEs) that target the bacterial cell membrane to address the growing threat of antimicrobial resistance. The project...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $481,250 to The Broad Institute, Inc. (Broad Institute of MIT and Harvard) on August 1, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award funds a two-year research project concluding July 31, 2027, focused on developing novel antimicrobial compounds based on induced proximity principles. The research involves designing chimeric molecules...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $899,935 to the Scripps Research Institute under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 10, 2025, to identify novel B cell epitopes against human coronaviruses. The research will utilize an integrated platform combining comprehensive characterization, high-resolution structural determination, state-of-the-art multi-bait B cell isolation strategies, and...
- Federal Project Grant Award Summary Cellia Science, Inc. received a $306,872 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded on September 5, 2025, with a completion date of August 31, 2026. The award supports the development of an innovative point-of-care (POC) diagnostic tool for Spontaneous Bacterial Peritonitis (SBP), a serious infection affecting 10-30% of hospitalized...
- Grant Award Summary The Scripps Research Institute received a $779,915 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded May 5, 2025, and extending through April 30, 2030. The research project investigates the chromatin remodeling functions of polyphosphate condensates in Pseudomonas aeruginosa, an opportunistic human pathogen. The research deliverables include scientific findings...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $883,119 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Scripps Research Institute to develop a novel mRNA vaccine and immunotherapy against hepatitis B virus (HBV) infection. The award supports research to investigate viral and cellular factors that hinder effective antigen expression and improve vaccine antigens to elicit potent antibody and T cell responses to cure HBV...